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Abstract
Purpose To conduct a systematic review of the literature
to determine important clinical predictors of surgical
outcome in patients with cervical spondylotic myelopathy
(CSM).
Methods A literature search was performed using MED-
LINE, MEDLINE in Process, EMBASE and Cochrane
Database of Systematic Reviews. Selected articles were
evaluated using a 14-point modified SIGN scale and clas-
sified as either poor (\7), good (7–9) or excellent (10–14)
quality of evidence. For each study, the association
between various clinical factors and surgical outcome,
evaluated by the (modified) Japanese Orthopaedic Asso-
ciation scale (mJOA/JOA), Nurick score or other measures,
was defined. The results from the EXCELLENT studies
were compared to the combined results from the
EXCELLENT and GOOD studies which were compared to
the results from all the studies.
Results The initial search yielded 1,677 citations. Ninety-
one of these articles, including three translated from
Japanese, met the inclusion and exclusion criteria and were
graded. Of these, 16 were excellent, 38 were good and 37
were poor quality. Based on the excellent studies alone, a
longer duration of symptoms was associated with a poorer
outcome evaluated on both the mJOA/JOA scale and
Nurick score. A more severe baseline score was related with a
worse outcome only on the mJOA/JOA scale. Based on the
GOOD and EXCELLENT studies, duration of symptoms
and baseline severity score were consistent predictors of
mJOA/JOA, but not Nurick. Age was an insignificant
predictor of outcome on any of the functional outcomes
considered.
Conclusion The most important predictors of outcome
were preoperative severity and duration of symptoms. This
review also identified many other valuable predictors
including signs, symptoms, comorbidities and smoking
status.
Keywords Cervical spondylotic myelopathy  Clinical
predictors  Surgical outcome  Systematic review
Introduction
Cervical spondylotic myelopathy (CSM) is the most com-
mon cause of spinal cord dysfunction worldwide. The
disease is caused by the degeneration of various compo-
nents of the vertebra, including the vertebral body, the
intervertebral disk, the supporting ligaments and the facet
joints [1]. Static factors, including the protrusion of oste-
ophytic spurs (spondylosis), disk desiccation, ossification
of the posterior longitudinal ligament (OPLL) and hyper-
trophy of the ligamentum flavum, may lead to the nar-
rowing of the spinal canal and to cord compression [2].
Longstanding compression of the spinal cord can result in
irreversible damage including demyelination and necrosis
of the gray matter. The onset of CSM is generally insidious
and progresses in a stepwise fashion [3, 4]. Upon diagnosis
of symptomatic CSM, a physician often recommends sur-
gical treatment to decompress the spinal cord [5]. Surgery
has proven to be an effective intervention for the full range
of myelopathy severity [6].
Given that CSM is a prevalent cause of spinal cord
injury, and since surgery is often an appropriate intervention,
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it would be useful to identify the most important predictors
of surgical outcome. Prediction is a valuable tool in a
clinical setting. Knowing a patient’s surgical outcome can
help determine which patients are most likely to benefit
from surgery and help assess their degree of functional
improvement [7]. This allows surgeons to provide valuable
prognostic information to concerned patients, helping to
manage expectations, as well as implement and direct
appropriate treatment programs.
Holly et al. [8] conducted a similar systematic review of
the literature and found that the most common predictors of
surgical outcome for patients with CSM were age, duration
of symptoms and severity of myelopathy. These three
clinical factors are most frequently reported in the litera-
ture. Controversy still remains as to the significance,
strength and direction of the relationship between surgical
outcome and age, duration of symptoms and baseline
severity.
The objective of this paper is to conduct a comprehen-
sive literature search to determine the most important
clinical predictors of outcome in surgical CSM-patients.
This paper will address whether age, duration of symptoms,
baseline severity score are indeed predictors and will also
examine other clinical factors including comorbidities,
smoking status, signs and symptoms to determine their
predictive value.
Materials and methods
A literature search was performed using MEDLINE,
MEDLINE in Process, EMBASE and Cochrane Central
Register of Controlled Trials. The keywords used for the
search were Cervical Spondylotic Myelopathy AND Sur-
gery or Postoperative AND Prediction/Prognosis AND
observational studies. The search was limited to humans,
aged 18 years or older. The total number of citations found
for this review was 1,677.
Articles were included if they were observational studies
on patients [18 years with degenerative cervical myelop-
athy, treated surgically and followed postoperatively.
Articles must have either directly or indirectly assessed the
ability of a clinical factor to predict surgical outcome.
Articles were eliminated if they were review articles or
opinions; studies on patients with traumatic spinal cord
injuries, thoracic myelopathy, radiculopathy, or non-
degenerative cervical myelopathy; studies assessing only
radiographic factors as predictors and studies that used
complications as an outcome measure. Articles that were
not in English or Japanese were excluded. Japanese articles
were translated by Dr. Iwasaki and were included in the
analysis.
All 1,677 abstracts and titles were reviewed indepen-
dently by two authors (LAT, AK) and were sorted based on
pre-determined inclusion and exclusion criteria. Figure 1
displays the search and review process in detail. Ninety-
one articles were included. Three of these were translated
from Japanese to English. Each article was assessed for
quality with respect to methodology and overall structure.
Several rating scales were examined, including Altman [9],
Hayden et al. [10], and the Scottish Inter-Collegiate
Guidelines Network (SIGN) scale for prognostic studies
[11]. A modified version of the SIGN scale was used to rate
the articles.
A modified version of the SIGN scoring system was
implemented in a systematic review published by Kalsi-
Ryan and Verrier [12]. Since the incidence of spinal cord
injury is comparatively low, high quality research in this
field is challenging. Studies often have small sample sizes
with no opportunity for blinded assessment and randomi-
zation. Kalsi-Ryan and Verrier modified SIGN so that it
was more specific to the nature of literature they were
reviewing. We selected the modified SIGN system and
further altered it to increase its applicability to literature
reporting clinical predictors of surgical outcome in patients
with CSM. Questions 15 and 16 were changed from
dichotomous scoring to trichotomous scoring as studies
may vary greatly in quality of statistical analysis, meth-
odology and bias elimination (Table 1). It was arbitrarily
decided that an article whose score was \7 would be
classified as POOR, 7–9 as GOOD and 10–14 as
EXCELLENT. The results from the EXCELLENT studies
were compared to the combined results from the
EXCELLENT and GOOD studies which were compared to
the results from all the studies.
For each study, the association between various clinical
factors and surgical outcome, evaluated by the (modified)
Japanese Orthopaedic Association scale (mJOA/JOA),
Nurick score or ‘‘other’’ measures, was extracted. A rela-
tionship between the outcome and predictor was defined as
conditional, if it was significant for certain groups of patients
but not others or using one statistical test, but not another.
Results
This review consisted of 37 POOR [13–49], 38 GOOD
[50–87] and 16 EXCELLENT [88–103] articles (Table 2).
Fifteen of these studies controlled for confounding
variables when looking at the association between outcome
and age, duration of symptoms and baseline severity score.
The outcome measure used in all EXCELLENT studies
was either the Nurick or the mJOA/JOA, with one study
commenting on both.
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Fig. 1 Search strategy and detailed review process. CSM cervical spondylotic myelopathy
Table 1 Modified Scottish Inter-collegiate Guidelines Network (SIGN) used to rate all articles





1. The study addresses an appropriate and clearly
focused question
6-point scale Yes = 1
No = 0
2. The two groups being studied are selected from
source populations that are comparable in all
respects other than the factor under
investigation
6-point scale –
3. The study indicates how many people were asked
to take part did so, in each of the groups being
studied
6-point scale Yes = 1
No = 0
Retrospective studies receive a score of zero
4. The likelihood that some eligible subjects
might have the outcome at the time of
enrolment is assessed and taken into account in
the analysis
6-point scale –
5. What percent (Did any) of individuals or clusters
recruited into each arm of the study dropped out
before the study was completed?
% Yes = 0
No = 1
Retrospective studies receive a score of zero unless
they commented on drop off rate ([80 %).
Prospective studies with a [80 % follow-up
receive a 1
6. Comparison is made between full participants
and those lost to follow-up, by exposure status
6-point scale –
7. The outcomes are clearly defined 6-point scale Yes = 1
No = 0
8. The assessment of outcome is made blind to
exposure status
6-point scale –
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Duration of symptoms
Thirteen articles evaluated duration of symptoms as a
predictor of surgical outcome. Nine reported a negative,
three a non-significant and one a conditional relationship. It
is evident that outcome, assessed on both the mJOA/JOA
and Nurick scale, is dependent on preoperative duration of
symptoms as indicated by significantly more articles
reporting a negative association than a non-significant
association. The R values for this negative relationship
ranged from weak to strong [95] (Table 3).
Baseline severity score
Nine articles reported on the relationship between baseline
severity score and surgical outcome. One article suggested
a negative, seven a positive and one a non-significant
association. All studies (7) that used JOA as the primary
outcome measure demonstrated that more severe preoper-
ative myelopathy is predictive of a worse outcome. When
assessing this association on the Nurick scale, there was
one article reporting a positive, one a negative and one an
insignificant relationship, making it difficult to draw a
conclusion as to the predictive value of preoperative
severity on Nurick. One study recorded a strong R value
(0.61) for this positive association [95] (Table 3).
Age
All 16 articles explored the importance of age on surgical
outcome. Six studies found a negative, eight a non-signif-
icant and two a conditional relationship. Breaking it down
by scale, two articles reported a negative and two a non-
association between age and Nurick. Four and six studies
Table 1 continued





9. Where blinding was not possible, there is some
recognition that knowledge of exposure status
could have influenced the assessment of
outcome
6-point scale –
10. The measure of assessment of exposure is
reliable
6-point scale Yes = 1
No = 0
11. Evidence from other sources is used to
demonstrate that the method of outcome
assessment is valid and reliable
6-point scale Yes = 1
No = 0
12. Exposure level or prognostic factor is assessed
more than once
6-point scale Yes = 1
No = 0
13. The main potential confounders are identified
and taken into account in the design and analysis
6-point scale Yes = 1
No = 0
The main confounders are age, duration of
symptoms and baseline severity score
14. Have confidence intervals been provided? 6-point scale Yes = 1
No = 0
Have the results been reported using good statistical
methods?
15. How well was the study done to minimize the
risk of bias or confounders, and to establish a
causal relationship between exposure and effect?






16. Taking into account clinical considerations, your
evaluation of the methodology used, and the
statistical power of the study, are you certain that
the overall effect is due to the exposure being
investigated?






17. Are the results of this study directly applicable to
the patient group targeted in this guideline?
Yes/No Yes = 1
No = 0
Checklist items in bold are those removed from the original checklist
a Question 15: To score a perfect 2, the study must be a prospective study with no selection and recruitment bias, must have a follow-up rate
[80 % and must have controlled for confounders. A prospective study that met some, but not all of this criteria scores a 1. A retrospective study
that has controlled for confounders also scores a 1. A highly biased retrospective or prospective study that has no control receives a score of 0
b Question 16: A study has sufficient statistical power if, for every predictor evaluated, there are at least 10 participants. Based on the score in
question 15, a study can either go up, go down one point or stay the same depending on whether its sample size meets this basic rule
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found a negative and a non-relationship, respectively,
between age and JOA/mJOA. It is unclear as to the asso-
ciation between age and outcome evaluated by Nurick, but
it is possible to suggest that age may not be predictive of
outcome on the JOA/mJOA scale. The two conditional
studies were not included in this count. Furlan et al. [91]
found that age was a significant predictor of outcome on
both scales using multiple regression, but not after
dichotomizing the mJOA outcome. In addition, Kim et al.
[93] suggested that age was an important predictor, but only in
patients with diabetes. The R values for this negative rela-
tionship ranged from moderate to strong (Table 3).
Most of the GOOD articles were not rated excellent due
to flaws in their statistical analysis such as a lack of control
for confounding variables. In contrast to the EXCELLENT
studies, the GOOD studies used a wider variety of scales and
measures to assess outcome such as the Cooper, neurosurgical
cervical spine scale (NCSS), neurological assessments,
questionnaires and evaluation of symptom improvement.
Duration of symptoms
Thirty-nine articles investigated duration of symptoms as a
potential predictor of outcome. Twenty-five reported a
negative, ten a non-significant and four a conditional
relationship. It is evident that there is a significant negative
association between duration of symptoms and outcome
evaluated on both the JOA/mJOA scale and other mea-
sures: 22 versus 8 articles identified a negative versus a
non-significant relationship. Using the Nurick scale, on the
other hand, the results were inconclusive: four articles
reported a negative and four a non-association. Inclusion of
the conditional articles did not alter these results. The
R values for this negative relationship ranged from weak to
strong (Table 3).
Baseline severity score
Thirty-eight studies assessed baseline severity score as a
potential predictor of surgical outcome. Five reported a
negative, 17 a positive, 12 a non-significant and 4 a con-
ditional relationship. It is evident that outcome, evaluated
by mJOA/JOA, is positively dependent on the baseline
severity score: 15 papers suggested a positive association,
while only 8 reported a non-significant relationship. It is
hard to define the relationship between baseline score and
Nurick score as two versus four papers reported negative
versus positive associations. It is clear that baseline score
is a significant predictor of Nurick, but the direction of
the relationship is unclear. With respect to all the other
outcome measures, two and three studies suggested a
negative and a non-significant relationship, respectively.
The R-values of this association ranged from moderate to
strong (Table 3).
Age
Fifty articles reported on age as a predictor of outcome.
Sixteen identified a negative, one a positive, 27 a non-
significant and 6 a conditional association between age and
outcome. Age was not found to be a predictor of outcome,
assessed using either the Nurick, mJOA/JOA or other
measures. Two and 14 papers found age had a negative
association with Nurick and JOA/mJOA, respectively. Five
and 18 studies, on the other hand, reported no relationship
with Nurick or JOA/mJOA, respectively. It is important to
incorporate the conditional studies into this analysis,
especially those that used JOA/mJOA as the primary out-
come measure. Both Nagashima et al. and Ogawa et al.
[74, 76] identified age as a significant predictor of outcome
in more severe myelopathy groups, but not in moderate
severity (10–12) groups. Furlan et al. [91] identified age as
an important negative predictor using multiple regression,
but not stepwise logistic regression. Finally, Koyanagi
et al. [69] suggested that age was a significant predictor in
patients with OPLL and CDH, but not CSM. Incorporating
these results into our assessment of age as a predictor, we
still conclude that it is an insignificant predictor. The
R values of the significant associations ranged from weak
to strong (Table 3).
The POOR studies had significant flaws, including study
design and poor statistical power and control. In addition,
many of these studies used unreliable outcome measures to
evaluate surgical improvement and suffered on their ratings
as a result.
Duration of symptoms
Sixty-three articles explored duration of symptoms as a
predictor of surgical outcome. Forty-two reported a nega-
tive, 16 a non-significant and 5 a conditional relationship.
The results were clear for all outcome measures: a longer
duration of symptoms was predictive of a worse outcome.
The R value of this association was reported in six studies
and ranged from weak to strong (Table 3).
Baseline severity score
Fifty-six papers assessed baseline severity score as a pre-
dictor of outcome. Twenty-nine reported a positive, 17 a
non-significant, 6 a negative and 4 a conditional associa-
tion. Baseline severity score was a definite positive pre-
dictor of outcome assessed using the JOA/mJOA and other
measures. Twenty-two versus ten papers reported a posi-
tive versus a non-significant association. The relationship
S244 Eur Spine J (2015) 24 (Suppl 2):S236–S251
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between baseline severity score and Nurick was inconclu-
sive: three papers identified as a negative, four a positive
and two a non-significant association. As in the good/
excellent analysis, it is evident that preoperative severity is
related to Nurick score, but the direction of this association
is unclear. The R value of this positive association was
reported in six studies and ranged from moderate to strong
(Table 3).
Age
Seventy-four studies commented on age as a potential
predictor. Twenty-seven identified a negative, 1 a positive,
40 a non-significant and 6 a conditional association. Age
was not a significant predictor of outcome, assessed using
either the Nurick score or other measures. Nine papers
reported a non-significant relationship between age and
Nurick, whereas only four suggested a negative relation-
ship. Without looking at the conditional associations, JOA/
mJOA was also not dependent on age as indicated by 25
articles reporting no relationship and 20 suggesting a
negative one. Five articles identified a conditional associ-
ation between age and mJOA/JOA. The results from these
studies do not affect these conclusions. The R values from
studies that reported an association ranged from weak to
moderate (Table 3).
Other predictors
Articles included in this review also explored the predictive
value of other factors including gender, signs and symp-
toms, disease progression pattern and various comorbidi-
ties. The results from these studies are displayed in
Table 4. There is no sufficient evidence in the literature to
conclude that the presence of a particular sign or symptom
or co-morbidity is predictive of outcome.
Discussion
This review compared the results from the EXCELLENT,
GOOD ? EXCELLENT and POOR ? GOOD ? EXCEL-
LENT papers (Table 5).
One of the major findings of this review was that
patients with a longer duration of symptoms and a more
severe baseline score are more likely to have an unfavor-
able surgical result. The rationale behind this finding is that
both severe and chronic, longstanding compression of the
spinal cord may lead to irreversible damage due to demy-
elination and necrosis of the gray matter. Secondly, con-
troversy exists in the literature as to the significance,
strength and direction of the relationship between surgical
outcome and age. Age was a non-significant predictor on
all the scales when looking at the GOOD ? EXCELLENT
and the POOR ? GOOD ? EXCELLENT studies. When
looking at only the higher quality studies (modified
SIGN C 10), however, age went from a non-significant
predictor to a potential predictor. Although most surgeons
will not discriminate on the basis of age, they should be
aware that the elderly are not able to translate neurological
recovery to functional improvement as well as the younger
population. Potential explanations for this discrepancy
include: (1) the elderly experience age related changes in
their spinal cord including a decrease in c-motoneurons,
number of anterior horn cells and number of myelinated
fibers in the corticospinal tracts and posterior funiculus, (2)
older patients are more likely to have unassociated
comorbidities that may affect outcome or (3) the elderly
may not be able to conduct all activities on a certain
functional scale due to these comorbidities (e.g. walking
time may be affected by osteoarthritis) [35, 75, 88, 92, 93].
Finally, our review determined that factors such as signs
(hyperreflexia, leg spasticity and Babinski sign), symptoms
(gait impairment, clumsy hands and numbness), comor-
bidities (diabetes and psychological issues), and smoking
status do carry some predictive value. Physicians should
progressively incorporate predictive modeling into their
practices to provide valuable prognostic information to
their patients and direct appropriate treatment programs.
When evaluating a CSM patient’s likely surgical outcome,
the surgeon must weigh his/her preoperative severity,
duration of symptoms and age accordingly while keeping
in mind the ability of other factors to affect the outcome.
As shown in this review, results may differ depending
on what scale is used to evaluate surgical outcome. This
may be due to limitations in the scales rather than an
indication of the actual association between the predictor
and outcome. The Nurick score is a scale with lower sen-
sitivity, it is graded out of five and is largely weighted
towards lower limb function [104]. When outcome was
assessed using the Nurick score, its association with vari-
ous predictors was less conclusive. For example, duration
of symptoms was significantly associated with Nurick
score when looking at the EXCELLENT and the POOR ?
GOOD ? EXCELLENT group, but was a questionable
predictor in the GOOD ? EXCELLENT group. In addi-
tion, in the GOOD ? EXCELLENT and POOR ?
GOOD ? EXCELLENT studies, there was a significant
relationship between preoperative condition and Nurick,
but the direction of the association was not evident. The
articles that identified a negative association, however, had
more biased samples: Gok et al., Huang et al. and
Rajshekhar and Kumar [22, 62, 97] all had stricter inclu-
sion criteria. On the other hand, the results were more
definite when the outcome was evaluated on either the JOA
or mJOA score: a longer duration of symptoms and a more
Eur Spine J (2015) 24 (Suppl 2):S236–S251 S245
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Furlan et al. [91]: number of comorbidities was not associated with postoperative Nurick or mJOA using stepwise
logistic regression
King et al. [94]: a greater number of comorbid diseases resulted in a worse outcome assessed by the Cooper scale
Nagata et al. [75]: a greater number of other health issues contributed to a poor surgical outcome in the older group
Presence of co-morbid
disease
Houten and Cooper [25]: presence of comorbidities is not related to outcome
Diabetes Chen et al., Kawaguchi et al. [30, 51]: diabetes is not a significant predictor of outcome
Kim et al., Choi et al. [53, 93]: diabetes is related to a worse outcome
Psychological disorders Kumar et al. [32]: patients in the poor outcome group had greater emotional problems than those in the good
outcome group
Smoking Kim et al. [93]: smoking status did not affect outcome in control group. In diabetes group, smoking increased the




Lee et al. [33]: not a significant predictor of outcome
Gregorius et al. [23]: presence of lower extremity weakness is associated with a worse outcome
Upper extremity
dysfunction
Lee et al. [33]: not a significant predictor of outcome
Magnaes and Hauge [34]: presence of arm symptoms is positively associated with leg outcome
Bowel/bladder
dysfunction
Houten and Cooper, Lee et al. [25, 33]: not a significant predictor of outcome
Gregorius et al., Sinha and Jagetia [23, 45]: presence of bladder/bowel dysfunction is associated with a worse
outcome
Babinski sign King et al. [94]: presence of a Babinski sign was associated with a worse outcome
Zhang et al. [102] presence of a Babinski sign was related with a better outcome




Gregorius et al. [23]: not a significant predictor of outcome
Alafifi et al., Bertalanffy and Eggert [17, 50]: presence of leg spasticity is associated with a worse outcome




Alafifi et al. [50]: both these signs were predictive of a worse outcome in patients with either a N/Hi or Lo/Hi MRI













Found to be insignificant predictors of outcome by single studies [23, 33]
Other
Gender 17 articles reported that gender is not a significant predictor of outcome [19, 22–24, 29, 33, 40, 51–54, 58, 59, 71,
81, 85, 91]
Emery et al. [55]: males showed greater improvement following surgery than females
Race Race is not a predictor of outcome [23]
Onset of symptoms Patients with a gradual onset of symptoms have a worse outcome [17]
Disease progression Patients with a slower progressing disease have a better outcome [37]
mJOA modified Japanese Orthopaedic scale, N/Hi normal/high, Lo/Hi low/high, MRI magnetic resonance imaging
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severe baseline severity score were associated with a worse
outcome. The mJOA and JOA are widely accepted stan-
dards for CSM assessment and separately evaluate lower
and upper limb, sphincter and sensory function. Although
JOA has been validated and shown to have high inter- and
intra-rater reliability [105], its modified version has not.
In a research setting, when looking at a relationship
between various factors and outcome, it is important to
control for the confounders baseline severity score and
duration of symptoms. When assessing statistical control in
our review to rate the articles, we ensured that the studies
controlled for age, duration of symptoms and baseline
severity as these were identified as important predictors by
Holly et al. [5]. According to this review, age may be a less
important confounder. Few articles reported on the R values
for the significant associations between various clinical
factors and outcome. This makes it difficult for clinicians
and researchers to evaluate the strength of these correlations.
Holly et al. [5] indicated that the limitations of their
review were that there were very few prospective studies,
that many studies assessed the outcome using un-validated
measures and that it was hard to analyze functional out-
come due to the use of different scales between studies.
Our study had much larger pool of articles and consisted of
higher quality literature, including some prospective stud-
ies that evaluated outcome using the validated JOA scale or
Nurick score. There was also a sufficient number of articles
to compare predictors on the same scale. In addition, the
differences in our methodology, including a comparison of
results among the three groups, also allowed for the
incorporation of quality assessment in the analysis. Since,
the Japanese have had a substantial contribution to research
in the field of spinal cord injury, including the creation of
the JOA scale, we also translated all Japanese articles into
English and incorporated them into our analysis. Finally,
our systematic review differed from Holly et al.’s as it
included a preliminary analysis of other predictors
including signs and symptoms, comorbidities, gender and
smoking status to determine their predictive value.
There are limitations to our study: (1) we did not sep-
arate studies based on length of follow-up time; (2) articles
that dichotomized a predictor might have done it differ-
ently (e.g. age) and (3) some of the articles with relevant
abstracts or titles were excluded because they were not
available or in another language other than Japanese or
English. Future systematic reviews should address these
limitations to provide a completely unbiased evaluation of
important predictors of outcome.
The results from this review should encourage further
exploration in this area. Even though many studies have
examined important predictors of surgical outcome in
CSM, there still remains a lack of evidence in the form of
high quality, prospective studies using validated outcome
measures. A large prospective analysis is required to
reemphasize the predictive value of duration of symptoms
and baseline severity score, to settle the controversy sur-
rounding age and to confirm that signs, symptoms and
comorbidities do impact surgical results.
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Table 5 Summary of results: percentages of articles reporting a negative, positive, non-significant or conditional association between surgical
outcome and duration of symptoms, baseline severity score or age
Negative Positive Non-significant Conditional
Excellent
Duration of symptoms 69 % NA 23 % 8 %
Baseline severity score 11 % 78 % 11 % NA
Age 37.5 % NA 50 % 12.5 %
Good ? excellent
Duration of symptoms 65 % NA 26 % 10 %
Baseline Severity Score 13 % 45 % 31.5 % 10.5 %
Age 32 % 2 % 54 % 12 %
Poor ? good ? excellent
Duration of symptoms 67 % NA 25 % 8 %
Baseline severity score 11 % 52 % 30 % 7 %
Age 36.5 % 1.5 % 54 % 8 %
Bold values indicate the relationship between predictor and outcome with the highest percentage
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